Search research articles
Contact Us
Filters
Showing results (151-160 of 164) with videos related to
Page
of 17
Sort By:
JTO Clinical and Research Reports
|
January 17, 2024
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma
Daisuke Hazama, Kenji Nakahama, Hiroaki Kodama, et al.
Frontiers in Neuroscience
|
July 19, 2019
STEFTR: A Hybrid Versatile Method for State Estimation and Feature Extraction From the Trajectory of Animal Behavior
Shuhei J Yamazaki, Kazuya Ohara, Kentaro Ito, et al.
Journal of Medicinal Chemistry
|
December 26, 2022
Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor
Ryutaro Kanada, Yoshiko Kagoshima, Takashi Suzuki, et al.
Cancer Medicine
|
April 17, 2024
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Cancer Science
|
July 9, 2020
Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data
Kentaro Ito, Kenta Murotani, Akihito Kubo, et al.
The Journal of Clinical Investigation
|
October 3, 2023
A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T
Kentaro Ito, Go Tajima, Chikako Kamisato, et al.
Cancers
|
August 26, 2022
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Scientific Reports
|
March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
Daichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting
Ryosuke Tsugitomi, Kento Takagi, Go Saito, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2021
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study
Kentaro Ito, Takeharu Yamanaka, Hidetoshi Hayashi, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 164) with videos related to
Sort By:
Page
of 17
JTO Clinical and Research Reports
|
January 17, 2024
Effectiveness and Safety of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in Pulmonary Sarcomatoid Carcinoma
Daisuke Hazama, Kenji Nakahama, Hiroaki Kodama, et al.
Frontiers in Neuroscience
|
July 19, 2019
STEFTR: A Hybrid Versatile Method for State Estimation and Feature Extraction From the Trajectory of Animal Behavior
Shuhei J Yamazaki, Kazuya Ohara, Kentaro Ito, et al.
Journal of Medicinal Chemistry
|
December 26, 2022
Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor
Ryutaro Kanada, Yoshiko Kagoshima, Takashi Suzuki, et al.
Cancer Medicine
|
April 17, 2024
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Cancer Science
|
July 9, 2020
Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data
Kentaro Ito, Kenta Murotani, Akihito Kubo, et al.
The Journal of Clinical Investigation
|
October 3, 2023
A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T
Kentaro Ito, Go Tajima, Chikako Kamisato, et al.
Cancers
|
August 26, 2022
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
Tadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Scientific Reports
|
March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
Daichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting
Ryosuke Tsugitomi, Kento Takagi, Go Saito, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2021
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study
Kentaro Ito, Takeharu Yamanaka, Hidetoshi Hayashi, et al.
Page
of 17